References
- Van Dam D, De Deyn PP. Drug discovery in dementia: the role of rodent models. Nat Rev Drug Discov. 2006;5:956–970.
- Van Dam D, De Deyn PP. Animal models in the drug discovery pipeline for Alzheimer’s disease. Br J Pharmacol. 2011;164:1285–1300.
- Mhatre SD, Paddock BE, Saunders AJ, et al. Invertebrate models of Alzheimer’s disease. J Alzheimers Dis. 2013;33:3–16.
- Van Dam D, De Deyn PP. Non human primate models for Alzheimer’s disease-related research and drug discovery. Expert Opin Drug Discov. 2017;12:187–200.
- Götz J, Ittner LM. Animal models of Alzheimer’s disease and frontotemporal dementia. Nat Rev Neurosci. 2008;9:532–544.
- Götz J, Bodea LG, Goedert M. Rodent models for Alzheimer disease. Nat Rev Neurosci. 2018;19:583–598.
- Gurumurthy CB, Lloyd KCK. Generating mouse models for biomedical research: technological advances. Dis Model Mech. 2019;12: pii: dmm029462.
- Festing MF. Evidence should trump intuition by preferring inbred strains to outbred stocks in preclinical research. Ilar J. 2014;55:399–404.
- Müller U. Ten years of gene targeting: targeted mouse mutants, from vector design to phenotype analysis. Mech Dev. 1999;82:3–21.
- Alzheimer’s disease research models. Alzforum. [cited 2019 Jul 12]. Available from: https://www.alzforum.org/research-models/alzheimers-disease
- Ameen-Ali KE, Wharton SB, Simpson JE, et al. Review: neuropathology and behavioural features of transgenic murine models of Alzheimer’s disease. Neuropathol Appl Neurobiol. 2017;43:553–570.
- Tschaharganeh DF, Lowe SW, Garippa RJ, et al. Using CRISPR/Cas to study gene function and model disease in vivo. Febs J. 2016;283:3194–3203.
- Geerts H. Of mice and men: bridging the translational disconnect in CNS drug discovery. CNS Drugs. 2009;23:915–926.
- Blackmore T, Meftah S, Murray TK, et al. Tracking progressive pathological and functional decline in the rTg4510 mouse model of tauopathy. Alzheimers Res Ther. 2017;9:77.